Entrada Therapeutics Inc — Balance Sheet (NASDAQ:TRDA) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Total assets 305.83 M252.06 M469.19 M526.32 M377.38 M Total liabilities 7.12 M39.5 M226.83 M97.64 M71.25 M Total equity 298.72 M212.55 M242.36 M428.68 M306.13 M Total liabilities & shareholders' equities 305.83 M252.06 M469.19 M526.32 M377.38 M Total debt ————— Net debt —————

Haberler

Entrada Therapeutics kazancı $0,04 ile beklentilere göre daha iyi, kâr ise beklentilere göre düşük

Entrada Therapeutics earnings beat by $0.04, revenue fell short of estimates

Arcutis Biotherapeutics, Inc. (ARQT) Surpasses Q4 Earnings and Revenue Estimates

Repligen (RGEN) Tops Q4 Earnings and Revenue Estimates

Earnings Preview: Entrada Therapeutics, Inc. (TRDA) Q4 Earnings Expected to Decline

EyePoint (EYPT) Surges 15.2%: Is This an Indication of Further Gains?

Illumina (ILMN) Tops Q4 Earnings and Revenue Estimates

Techne (TECH) Beats Q2 Earnings and Revenue Estimates

Entrada Therapeutics, Inc. (TRDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Capricor Therapeutics Stock: A High Risk/High Reward Name (NASDAQ:CAPR)

Entrada DMD tedavileri konusunda ilerleme kaydediyor, klinik takvimi paylaşıyor

Entrada reports progress on DMD treatments, shares clinical timeline